The Hartford partners with Yale-PAM
Workers’ compensation and disability insurer The Hartford announced a new partnership with the Yale Program in Addiction Medicine (Yale-PAM) to develop a training program focused on addiction, pain management, and stigma for Connecticut medical providers who treat injured workers.
“The loss and suffering caused by the ongoing opioid crisis is heartbreaking, and now more than ever, it’s important that we all take action to dispel addiction stigma and engage with empathy. We know from our decades of experience that front-line clinicians play a critical role in preventing substance misuse and fostering treatment. That’s why we are honored to partner with an internationally-recognized innovator in addiction treatment on this new training, which will lead to better care for those in need.” – The Hartford’s Chairman and CEO Christopher Swift.
Led by David Fiellin, M.D., and Jeanette Tetrault, MD, FACP, FASAM, the Yale-PAM will develop the training that will help clinicians identify and treat acute pain, chronic pain, substance misuse, and substance and opioid use disorders among Connecticut workers. The training will be geared toward the use of person-centered and non-stigmatizing approaches to addressing pain and addiction and will focus on improved function, as well as a safe return to work.
Phase one of the pilot, which is underway now, includes developing the training modules and a compendium of clinically relevant resources. In phase two, slated for January to June 2022, the training will be delivered to a preliminary cohort of 50 to 100 Connecticut medical professionals, who treat workers with acute pain, living with chronic pain and/or a substance use disorder. In the final phase of the pilot, the modules will be updated based on the medical providers’ feedback, which is anticipated for the third quarter of 2022.
“We are grateful for The Hartford’s commitment to sustaining evidence-based treatment and the education of professionals who care for injured workers. We hope this pilot will produce a national educational resource that helps millions of individuals return to active, productive lives – without stigma or untreated addiction.” – David Fiellin, M.D.
“I applaud The Hartford and the Yale School of Medicine for leading the way in providing internationally-recognized innovative training to help curb the opioid epidemic, which has a corrosive grip on communities here in Connecticut and across the country. Compounded by the loss of loved ones and isolation caused by the COVID crisis, the heartbreaking numbers of people lost to substance use disorder continues to soar. It’s long past time we remove the stigma from this illness and implement more widely appropriate medical and evidence-based treatments.” – U.S. Sen. Richard Blumenthal.
